Alexander R Anderson

57PUBLICATIONS
155CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Statistical mechanics, physical combinatorics and mathematical aspects of condensed matterCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (57)

|Sep 11, 2026
KRAS-G12C inhibition-induced enrichment of MHC-Ihigh immune-active tumor cells directs immune-effector TME development to augment therapeutic efficacy.

|May 29, 2026
Multifactorial sheltering in peristromal niches shapes in vivo responses of lung cancers to targeted therapies.

|May 22, 2026
Evolutionary Antifragile Therapy Is a Treatment Strategy to Suppress Drug Resistance by Exploiting Dose-Response Convexity.

|Mar 27, 2026
A novel combination therapy for ER+ breast cancer suppresses drug resistance via an evolutionary double-bind.

Rena Emond, Jeffrey West, Vince K Grolmusz

|Feb 06, 2026
75 Years of Mathematical Oncology.

Franco Pradelli, Maximilian Strobl, Sadegh Marzban

|Dec 19, 2025
Distinct Tumor-Immune Ecologies in Patients with Lung Cancer Predict Progression and Define a Clinical Biomarker of Therapy Response.

Sandhya Prabhakaran, Chandler D Gatenbee, Mark Robertson-Tessi

Pageof 10

Frequent Collaborators

17 joint publications

Jeffrey West

15 joint publications

Mark Robertson-Tessi

11 joint publications

Chandler Gatenbee

10 joint publications

Maximilian Strobl